 |
| Karen Boykin-Towns |
Karen Boykin-Towns, who was VP-corporate affairs for Pfizer’s $34B innovate medicines unit and is vice chairman of the National Assn. for the Advancement of Colored People, has joined Sard Verbinnen & Co. as senior counselor.
She will advise the financial PR shop on healthcare, PA, diversity, crisis, governance and social issues and pitch in on business development work.
Boykin-Towns had a 22-year run at Pfizer, working in government relations, PA, global policy and human resources. She served as the pharmaceutical giant’s first chief diversity officer.
Before working at Pfizer, she was chief of staff and legislative director for New York State senator David Paterson, who went on to become governor of the Empire State.
Interpublic posted a 5.1 percent drop in Q3 net revenues to $2.5B as CEO Philippe Krakowsky reports the final financial results of the publicly traded company.
Joele Frank handles Pine Gate Renewables as the Asheville, NC-based solar power development company declares Chapter 11 in the aftermath of Donald Trump’s cuts to wind & solar tax credits.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
